Biogen (BIIB) Receivables - Other (2009 - 2024)
Biogen (BIIB) posted quarterly Receivables - Other of $82.3 million for Q3 2024, down 94.15% year-over-year from $1.4 billion in Q4 2023, and up 6.33% quarter-over-quarter from $77.4 million in Q2 2024.
Biogen (BIIB) Receivables - Other (2009 - 2024) Analysis & Trends
Biogen's Receivables - Other history runs 10 years deep, the most recent figure standing at $82.3 million for Q3 2024.
- In Q3 2024, Receivables - Other fell 94.15% year-over-year to $82.3 million; the TTM figure through Sep 2024 stood at $82.3 million (down 94.15% YoY), while the FY2023 annual figure was $117.5 million, up 5775.0% from the prior year.
- Receivables - Other for Q3 2024 stood at $82.3 million, up from $77.4 million in the prior quarter.
- The five-year high for Receivables - Other was $1.4 billion in Q3 2023, with the low at $3.8 million in Q1 2020.
- The 5-year median for Receivables - Other is $99.9 million (2023), against an average of $316.4 million.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other plunged 98.44% in 2023, then jumped 1157.14% in 2024.
- Biogen's Receivables - Other stood at $151.1 million in 2020, then soared by 88.88% to $285.4 million in 2021, then surged by 215.35% to $900.0 million in 2022, then tumbled by 86.94% to $117.5 million in 2023, then declined by 29.96% to $82.3 million in 2024.
- Business Quant data shows BIIB's Receivables - Other at $82.3 million in Q3 2024, $77.4 million in Q2 2024, and $79.2 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 82.30 Mn |
| Sep 30, 2024 | 82.30 Mn |
| Jun 30, 2024 | 77.40 Mn |
| Jun 30, 2024 | 77.40 Mn |
| Mar 31, 2024 | 79.20 Mn |
| Mar 31, 2024 | 79.20 Mn |
| Dec 31, 2023 | 117.50 Mn |
| Dec 31, 2023 | 117.50 Mn |
| Sep 30, 2023 | 1.41 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 6.30 Mn |
| Mar 31, 2023 | 6.30 Mn |
| Sep 30, 2022 | 900.00 Mn |
| Sep 30, 2022 | 900.00 Mn |
| Jun 30, 2022 | 900.00 Mn |
| Jun 30, 2022 | 900.00 Mn |
| Mar 31, 2022 | 402.70 Mn |
| Mar 31, 2022 | 402.70 Mn |
| Dec 31, 2021 | 285.40 Mn |
| Dec 31, 2021 | 285.40 Mn |